SULFATHIAZOLE URINARY CALCULI IN THE KIDNEYS, URETERS AND BLADDER

Publisher Website
Google Scholar
Abstract
Sulfathiazole (2 sulfanilamide-thiazole) is the newest of the group of chemotherapeutic agents employed in the treatment of pneumococcic pneumonia. Its efficacy in pneumonia is being thoroughly investigated in many of the larger hospitals in this country. Clinical reports1and our own results show that in its therapeutic effects sulfathiazole in pneumonia compares favorably with sulfapyridine and that it is preferable to sulfanilamide. It also has the added advantage of being less toxic and less likely to cause some of the complications encountered after the use of either of these other drugs. Since sulfathiazole is still on trial it is important to record any of the complications or sequelae that may arise from its use. Reinhold, Flippin and Schwartz2observed that sulfathiazole is not as readily reabsorbed from the kidney tubules as are sulfapyridine and sulfanilamide. Gross, Cooper and Scott3reported the formation of sulfathiazole crystals in the

This publication has 0 references indexed in Scilit: